Molecular pathways: interferon/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growth

Nikolai N Khodarev1, Bernard Roizman, Ralph R Weichselbaum

  • 1Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.

Insights

Signal transducer and activator of transcription 1 (STAT1) has dual roles in cell signaling, impacting both defense and aggressive tumor growth. New inhibitors may clarify its complex functions.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Immunology

Background:

  • Signal transducer and activator of transcription 1 (STAT1) is activated by interferons (IFNs) and other cellular signals.
  • Activated STAT1 translocates to the nucleus, initiating the transcription of IFN-stimulated genes.
  • Traditionally linked to antiviral defense and tumor suppression, STAT1's role is increasingly recognized as complex.

Purpose of the Study:

  • To explore the dual functions of the STAT1 pathway in cellular responses.
  • To investigate the emerging roles of STAT1 in DNA damage resistance and tumor progression.
  • To highlight recent therapeutic developments targeting the STAT1 pathway.

Main Methods:

  • Review of existing literature on STAT1 activation and function.
  • Analysis of studies demonstrating STAT1's role in DNA damage response.
  • Examination of research on STAT1's involvement in tumor growth and metastasis.

Main Results:

  • STAT1 activation by IFNs is crucial for innate immunity.
  • STAT1 pathway expression confers resistance to DNA-damaging agents.
  • STAT1 signaling can mediate aggressive tumor growth and influence the tumor microenvironment.

Conclusions:

  • The STAT1 pathway exhibits context-dependent, dual functions in cellular processes.
  • Understanding STAT1's complex roles is critical for developing effective cancer therapies.
  • Janus-activated kinase (JAK)/STAT inhibitors offer potential for modulating STAT1 activity.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...